General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase-Reference-Cited by-同舟云学术

General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase

Published:1994-09 Issue:5 Volume:25 Page:813-824
ISSN:0306-3623
Container-title:General Pharmacology: The Vascular System
language:en
Short-container-title:General Pharmacology: The Vascular System

Author:

Kaakkola Seppo,Gordin Ariel,Männistö Pekka T.

Publisher

Elsevier BV

Subject

Pharmacology

Reference89 articles.

1. Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592;Acquas;J. Neurochem.,1992

2. Effect of COMT inhibition by CGP 28 014 N-(6-hydroxy-2-pyridyl)-N′-di-N-propyl formamidine) on plasma dopa and 3OMD in humans;Antonin;Vth Clinical Pharmacology & Therapeutics,1992

3. Enzymatic O-methylation of epinephrine and other catechols;Axelrod;J. biol. Chem.,1958

4. O-methylation of catechol amines in vivo;Axelrod;J. biol. Chem.,1958

5. Synthesis of some novel potent and selective catechol-O-methyltransferase inhibitors;Bäckström;J. med. Chem.,1989

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methyltransferases;Reference Module in Biomedical Sciences;2024

2. Entacapone/Tolcapone/Opicapone for Treating Parkinson’s Disease;NeuroPsychopharmacotherapy;2022

3. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol;CNS & Neurological Disorders - Drug Targets;2021-11-03

4. Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone;Expert Review of Neurotherapeutics;2021-09-02

5. Parkinson's disease;Drug Delivery Devices and Therapeutic Systems;2021